Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Vogel, A, Cervantes, A, Chau, I, Daniele, B, Llovet, J M, Meyer, T, Nault, J -C, Neumann, U, Ricke, J, Sangro, B, Schirmacher, P, Verslype, C, Zech, C J, Arnold, D, Martinelli, E
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Vogel, A, Cervantes, A, Chau, I, Daniele, B, Llovet, J M, Meyer, T, Nault, J -C, Neumann, U, Ricke, J, Sangro, B, Schirmacher, P, Verslype, C, Zech, C J, Arnold, D, Martinelli, E
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types
Paré, L., Pascual, T., Seguí, E., Teixidó, C., Gonzalez-Cao, M., Galván, P., Rodríguez, A., González, B., Cuatrecasas, M., Pineda, E., Torné, A., Crespo, G., Martin-Algarra, S., Pérez-Ruiz, E., Reig, Ò, Viladot, M., Font, C., Adamo, B., Vidal, M., Gaba, L., Muñoz, M., Victoria, I., Ruiz, G., Viñolas, N., Mellado, B., Maurel, J., Garcia-Corbacho, J., Molina-Vila, M Á, Juan, M., Llovet, J.M., Reguart, N., Arance, A., Prat, A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation
Llovet, J M, Mas, X, Aponte, J J, Fuster, J, Navasa, M, Christensen, E, Rodés, J, Bruix, J
Published in Gut (01.01.2002)
Published in Gut (01.01.2002)
Get full text
Journal Article
New molecular therapies for hepatocellular carcinoma
Torrecilla, S, Llovet, J.M
Published in Clinics and research in hepatology and gastroenterology (01.09.2015)
Published in Clinics and research in hepatology and gastroenterology (01.09.2015)
Get full text
Journal Article
Corrigendum to “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology 29 suppl. 4 (2018) v238–iv255]
Vogel, A., Cervantes, A., Chau, I., Daniele, B., Llovet, J.M., Meyer, T., Nault, J.-C., Neumann, U., Ricke, J., Sangro, B., Schirmacher, P., Verslype, C., Zech, C.J., Arnold, D., Martinelli, E.
Published in Annals of oncology (01.06.2022)
Published in Annals of oncology (01.06.2022)
Get full text
Journal Article
New aspects of diagnosis and therapy of hepatocellular carcinoma
Bruix, J, Hessheimer, A J, Forner, A, Boix, L, Vilana, R, Llovet, J M
Published in Oncogene (26.06.2006)
Published in Oncogene (26.06.2006)
Get full text
Journal Article
LBA34 Primary results from the phase III LEAP-002 study: Lenvatinib plus pembrolizumab versus lenvatinib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC)
Finn, R.S., Kudo, M., Merle, P., Meyer, T., Qin, S., Ikeda, M., Xu, R., Edeline, J., Ryoo, B-Y., Ren, Z., Cheng, A-L., Galle, P.R., Kaneko, S., Kumada, H., Wang, A., Mody, K., Dubrovsky, L., Siegel, A.B., Llovet, J.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
Ducreux, M., Abou-Alfa, G.K., Bekaii-Saab, T., Berlin, J., Cervantes, A., de Baere, T., Eng, C., Galle, P., Gill, S., Gruenberger, T., Haustermans, K., Lamarca, A., Laurent-Puig, P., Llovet, J.M., Lordick, F., Macarulla, T., Mukherji, D., Muro, K., Obermannova, R., O’Connor, J.-M., O’Reilly, E.M., Osterlund, P., Philip, P., Prager, G., Ruiz-Garcia, E., Sangro, B., Seufferlein, T., Tabernero, J., Verslype, C., Wasan, H., Van Cutsem, E.
Published in ESMO open (01.06.2023)
Published in ESMO open (01.06.2023)
Get full text
Journal Article
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma
Llovet, Josep M., Vilana, Ramon, Brú, Concepció, Bianchi, Lluı́s, Salmeron, Joan Manuel, Boix, Loreto, Ganau, Sergi, Sala, Margarita, Pagès, Mario, Ayuso, Carmen, Solé, Manel, Rodés, Joan, Bruix, Jordi
Published in Hepatology (Baltimore, Md.) (01.05.2001)
Published in Hepatology (Baltimore, Md.) (01.05.2001)
Get full text
Journal Article
Hepatocellular carcinoma
LLOVET, Josep M, BURROUGHS, Andrew, BRUIX, Jordi
Published in The Lancet (British edition) (06.12.2003)
Published in The Lancet (British edition) (06.12.2003)
Get full text
Journal Article
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP) following first-line sorafenib: Patient reported outcome results across two phase III studies (REACH-2 and REACH)
Zhu, A.X., Finn, R.S., Galle, P.R., Llovet, J.M., Blanc, J.F., Okusaka, T., Chau, I., Cella, D., Girvan, A., Gable, J., Bowman, L., Hsu, Y., Abada, P.B., Kudo, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP) following first-line sorafenib: Pooled efficacy and safety across two global randomized Phase 3 studies (REACH-2 and REACH)
Zhu, A., Finn, R., Galle, P., Llovet, J., Blanc, J F, Okusaka, T., Chau, I., Abada, P., Hsu, Y., Kudo, M.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Ramucirumab in advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: outcomes by prior transarterial chemoembolisation from two randomised, double-blind, placebo-controlled phase 3 studies (REACH-2 and REACH)
Meyer, T., Finn, R., Kudo, M., Kang, Y., Yen, C., Galle, P., Llovet, J., Assenat, E., Brandi, G., Motomura, K., Okusaka, T., Hubner, R., Karwal, M., Baron, A., Ikeda, M., Liang, K., Wang, C., Widau, R., Schelman, W., Zhu, A.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials
Llovet, Josep M., Bustamante, Javier, Castells, Antoni, Vilana, Ramon, Ayuso, Maria Del Carmen, Sala, Margarita, Brú, Concepció, Rodés, Joan, Bruix, Jordi
Published in Hepatology (Baltimore, Md.) (01.01.1999)
Published in Hepatology (Baltimore, Md.) (01.01.1999)
Get full text
Journal Article